Note that some links may require subscriptions.
U.S. House passes a bipartisan bill that aims to prevent maternal deaths. (The Hill)
A powerful new opioid was pitched as a battlefield necessity, but will sufentanil sublingual tablets (Dsuvia) deliver the rapid pain relief promised? (STAT)
FDA announces a strongly worded warning letter to the Chinese manufacturer producing the active ingredient involved in some of the valsartan recalls.
FDA approves SUBA-itraconazole (Tolsura), a new formulation for treating adults with the systemic fungal infections aspergillosis, blastomycosis, and histoplasmosis, manufacturer Mayne Pharma announced.
And proving that split votes by FDA advisory committees mean little, the agency declined to approve Mallinckrodt’s supposedly abuse-deterrent oxycodone product, despite a committee’s 10-7 vote in favor of approval last month. (Reuters)
The CEO of Johns Hopkins All Children’s Hospital in Tampa resigns following reports from the Tampa Bay Times that the mortality rate there tripled from 2015 to 2017.
Fentanyl, heroin, cocaine, methamphetamine: the top four drugs (in order) involved in overdose deaths in 2016, according to the most recent data from the CDC.
Jimmy Dean frozen pork and poultry sausage links are being recalled — roughly 29,000 pounds’ worth — after consumers complained of metal pieces in the meat. (NBC News)
McDonald’s says it plans to reduce the amount of antibiotics in its hamburgers. (NPR)
How much does a breast implant cost? Depends what it’s for, and who’s picking up the tab. (Kaiser Health News)
A woman’s viral tweets warns on how heart attack symptoms in women can be insidious and go unrecognized. (BuzzFeed)
How does the public shaming of heroin addicts with YouTube videos of them overdosing go on to affect their lives? (New York Times)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]